○Kenji Sakakibara1, Yuta Imai2, Madoka Iida1, Kentaro Sahashi1, Ryuji Kato2, Masahisa Katsuno1 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Nagoya University)
Session information
Poster Presentation Award Nominee Session (Basic Research)
[AP-01] Poster Presentation Award Nominee Session (Basic Research)
Wed. May 18, 2022 5:20 PM - 6:35 PM Poster (Tokyo International Forum E Block B2F Hall E)
Chair:Osamu Onodera(Brain Research Institute, Niigata University.)
○Aya Ikeda1, Manabu Funayama1, Mari Yoshida2, Yuanzhe Li1, Tsuyoshi Inoshita3, Kahori Shiba-fukushima4, Hongrui Meng3, Taku Amo5, Ikuko Aiba6, Yufuko Saito6, Naoki Atsuta7, Ryoichi Nakamura7, Genki Tohnai7, Jun Sone2, Yuishin Izumi8, Ryuji Kaji8, Mitsuya Morita9, Akira Taniguchi10, Kenya Nishioka1, Yuzuru Imai1, Gen Sobue7, Nobutaka Hattori1, JaCALS7 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Department of Neurology, Mie University Graduate School of Medicine, 3.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan., 4.Department of Neurodegenerative and Demented Disorders, Juntendo University Graduate School of Medicine., 5.Department of drug development for Parkinson's disease, 6.Department of Applied Chemistry, National Defense Academy, 7.Department of Neurology, National Hospital Organization Higashinagoya National Hospital., 8.Aichi Medical University., 9.Department of Clinical Neuroscience, Tokushima University Graduate School, 10.Division of Neurology, Department of Internal Medicine, Jichi Medical University)
○Tomoya Taminato1, Morio Ueyama1, Toru Yamashita3, Yoshio Ikeda2, Koji Abe4, Yoshitaka Nagai1 (1.Dept Neurology, Kinki Univ, Osaka, Japan, 2.Dept Neurology, Gunma Univ Grad Sch of Med, Gunma, Japan, 3.Dept Neurology, Okayama Univ Grad Sch of Med, Okayama, Japan, 4.Dept Neurology, National Center Neurol and Psychiatry, Tokyo, Japan)
○Takashi Ando1,2, Yuichi Riku1,2, Akio Akagi2, Hiroaki Miyahara2, Jun Sone2, Masahisa Katsuno1, Mari Yoshida2, Yasushi Iwasaki2 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Japan)
○Chihiro Namatame1, Tatsuro Misu1, Yoichiro Abe2, Yuki Matsumoto1, Yoshiki Takai1, Masato Yasui2, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Pharmacology, Keio University Graduate School of Medicine)
○Kensuke Daida1, Shotaro Shimonaka2,3, Kahori Shiba4, Jun Ogata5, Hiroyo Yoshino3, Ayami Okuzumi1, Taku Hatano1, Yumiko Motoi1,2, Manabu Funayama1,3, Tomoki Hirunagi6, Masahisa Katsuno6, Kenya Nishioka1, Yuzuru Imai1,5, Nobutaka Hattori1,2,3,4,5 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Department of Diagnosis, Prevention and Treatment of Dementia, Juntendo University Graduate School of Medicine, 3.Research Institute for Diseases of Old Age, Juntendo University Graduate School of Medicine, 4.Department of drug development for Parkinson's disease, Juntendo University Graduate School of Medicine, 5.Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, 6.Department of Neurology, Nagoya University Graduate School of Medicine)